Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Carcinoma in Older Patients.
暂无分享,去创建一个
G. Weinstein | A. Chalian | R. Cohen | J. Lukens | S. Swisher-McClure | A. Lin | J. Newman | C. Aggarwal | C. Rassekh | K. Rajasekaran | S. Cannady | R. Brody | J. Bauml | H. Parhar | D. Shimunov | Bert W O' Malley | Bert W O 'malley
[1] E. Mendez,et al. Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311). , 2020 .
[2] G. Lawson,et al. Bleeding Complications After Transoral Robotic Surgery: A Meta‐Analysis and Systematic Review , 2020, The Laryngoscope.
[3] G. Weinstein,et al. A Phase II Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed Following Transoral Robotic Surgery for Human Papilloma Virus Related Squamous Cell Carcinoma of the Oropharynx. , 2019, International journal of radiation oncology, biology, physics.
[4] M. Luu,et al. Survival outcomes with concomitant chemoradiotherapy in older adults with oropharyngeal carcinoma in an era of increasing human papillomavirus (HPV) prevalence. , 2019, Oral oncology.
[5] D. Kallogjeri,et al. Multi‐institutional analysis of outcomes following transoral surgery for HPV‐positive oropharyngeal squamous cell carcinoma in elderly patients , 2019, Head & neck.
[6] K. Fung,et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. , 2019, The Lancet. Oncology.
[7] E. Genden,et al. Trimodality therapy for oropharyngeal cancer in the TORS era: Is there a cohort that may benefit? , 2019, Head & neck.
[8] Joaquim M Farinhas,et al. Occult Nodal Disease and Occult Extranodal Extension in Patients With Oropharyngeal Squamous Cell Carcinoma Undergoing Primary Transoral Robotic Surgery With Neck Dissection. , 2019, JAMA otolaryngology-- head & neck surgery.
[9] P. Rosenberg,et al. Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] E. Prisman,et al. Analysis of readmissions after transoral robotic surgery for oropharyngeal squamous cell carcinoma , 2018, Head & neck.
[11] W. Westra,et al. Increasing prevalence of human papillomavirus–positive oropharyngeal cancers among older adults , 2018, Cancer.
[12] E. Prisman,et al. Patient Choice of Nonsurgical Treatment Contributes to Disparities in Head and Neck Squamous Cell Carcinoma , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[13] K. Fung,et al. Development of an online, patient-centred decision aid for patients with oropharyngeal cancer in the transoral robotic surgery era. , 2017, Current oncology.
[14] Dylan F. Roden,et al. Triple‐modality treatment in patients with advanced stage tonsil cancer , 2017, Cancer.
[15] P. Gravitt,et al. Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution , 2017, The Journal of infectious diseases.
[16] K. Brintzenhofeszoc,et al. The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment. , 2017, International journal of radiation oncology, biology, physics.
[17] N. Lee,et al. The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity‐modulated radiotherapy era , 2017, Cancer.
[18] M. Goodman,et al. Incidence of Oropharyngeal Cancer Among Elderly Patients in the United States. , 2016, JAMA oncology.
[19] D. Kutler,et al. Adoption of transoral robotic surgery compared with other surgical modalities for treatment of oropharyngeal squamous cell carcinoma , 2016, Journal of surgical oncology.
[20] F. Khuri,et al. Clinical outcomes in elderly patients with human papillomavirus–positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapy , 2016, Head & neck.
[21] Brian J. Alleva. The Longevity Visualizer: An Analytic Tool for Exploring the Cohort Mortality Data Produced by the Office of the Chief Actuary , 2016 .
[22] M. Crary,et al. Prevalence of and risk factors for dysphagia in the community dwelling elderly: A systematic review , 2016, The journal of nutrition, health & aging.
[23] E. Genden,et al. Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study. , 2015, JAMA otolaryngology-- head & neck surgery.
[24] E. Genden,et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review , 2014, The Laryngoscope.
[25] Barton F Branstetter,et al. Accuracy of computed tomography in the prediction of extracapsular spread of lymph node metastases in squamous cell carcinoma of the head and neck. , 2013, JAMA otolaryngology-- head & neck surgery.
[26] M. Daly,et al. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer. , 2013, American journal of otolaryngology.
[27] B. Chera,et al. Treatment of older patients with head and neck cancer: a review. , 2013, The oncologist.
[28] G. Weinstein,et al. Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins , 2012, The Laryngoscope.
[29] G. Weinstein,et al. Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. , 2012, Archives of otolaryngology--head & neck surgery.
[30] Gypsyamber D'Souza,et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. , 2010, The Lancet. Oncology.
[31] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[32] J. Pignon,et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[33] Y. Agrawal,et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. , 2009, The Journal of infectious diseases.
[34] A. Garden,et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] A. Chaturvedi,et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Erik von Elm,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. , 2007, International journal of surgery.
[37] Valery E P P Lemmens,et al. Comorbidity in older surgical cancer patients: influence on patient care and outcome. , 2007, European journal of cancer.
[38] Charles E McCulloch,et al. Relaxing the rule of ten events per variable in logistic and Cox regression. , 2007, American journal of epidemiology.
[39] J. Samet,et al. Comorbidity and survival of elderly head and neck carcinoma patients , 2001, Cancer.
[40] R. Rosenfeld,et al. Validation of the Charlson Comorbidity Index in Patients With Head and Neck Cancer: A Multi‐institutional Study , 1997, The Laryngoscope.
[41] H. Lynch,et al. Psychologic Aspects of Cancer Genetic Testing: A Research Update for Clinicians , 1997 .
[42] I. Fentiman,et al. Cancer in the elderly: why so badly treated? , 1990, The Lancet.
[43] P. Hudgins,et al. Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection. , 2014, International journal of radiation oncology, biology, physics.
[44] Jordi Giralt,et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. , 2010, The Lancet. Oncology.
[45] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[46] J. Cooper. Ajcc Cancer Staging Manual , 1997 .
[47] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.